InsidersTradesSigma
Follow the 誉衡药业 share price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 誉衡药业 has recorded 2 insider filings. Market capitalisation: €6.4bn. The latest transaction was disclosed on 1 July 2025 (Sale). Among the most active insiders: 李润宝. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
誉衡药业 is a company focused on the health and pharmaceutical sector, specializing in the development and manufacturing of medications. It is listed on the XSHE market.